The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1564
ISSUE1564
January 28, 2019
Qbrexza - A Glycopyrronium Cloth for Axillary Hyperhidrosis
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Qbrexza - A Glycopyrronium Cloth for Axillary Hyperhidrosis
January 28, 2019 (Issue: 1564)
Qbrexza (Dermira), a premoistened cloth containing
the long-acting anticholinergic drug glycopyrronium,
has been approved by the FDA for once-daily topical
treatment of excessive underarm sweating (primary
axillary hyperhidrosis) in patients ≥9...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.